These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26087622)

  • 1. [Genetic Cell Reprogramming: A New Technology for Basic Research and Applied Usage].
    Bogomazova AN; Vassina EM; Kiselev SI; Lagarkova MA; Lebedeva OS; Nekrasov ED; Panova AV; Philonenko ES; Khomyakova EA; Tskhovrebova LV; Chestkov IV; Shutova MV
    Genetika; 2015 Apr; 51(4):466-78. PubMed ID: 26087622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Avian Induced Pluripotent Stem Cells.
    Lu Y; West FD; Jordan BJ; Beckstead RB; Jordan ET; Stice SL
    Methods Mol Biol; 2015; 1330():89-99. PubMed ID: 26621592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cells in medicine and biology.
    Takahashi K; Yamanaka S
    Development; 2013 Jun; 140(12):2457-61. PubMed ID: 23715538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reprogramming mechanism and genetic stability of induced pluripotent stem cells (iPSCs)].
    Ren C; Sun H; Wang L; Zhang G; Fan Y; Yan G; Wang D; Wang F
    Yi Chuan; 2014 Sep; 36(9):879-87. PubMed ID: 25252305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reprogramming of somatic cells. Problems and solutions].
    Schneider TA; Fishman VS; Liskovykh MA; Ponamartsev SV; Serov OL; Tomilin AN; Alenina N
    Tsitologiia; 2014; 56(12):869-80. PubMed ID: 25929128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Induced Pluripotent Stem Cells from Mammalian Endangered Species.
    Ben-Nun IF; Montague SC; Houck ML; Ryder O; Loring JF
    Methods Mol Biol; 2015; 1330():101-9. PubMed ID: 26621593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?
    Bilic J; Izpisua Belmonte JC
    Stem Cells; 2012 Jan; 30(1):33-41. PubMed ID: 22213481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of small molecules on cell reprogramming.
    Baranek M; Belter A; Naskręt-Barciszewska MZ; Stobiecki M; Markiewicz WT; Barciszewski J
    Mol Biosyst; 2017 Jan; 13(2):277-313. PubMed ID: 27918060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of induced pluripotent stem cells.
    Deyle DR
    Methods Mol Biol; 2015; 1226():43-58. PubMed ID: 25331042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of induced pluripotent stem cells from virus-free in vivo reprogramming of BALB/c mouse liver cells.
    de Lázaro I; Bussy C; Yilmazer A; Jackson MS; Humphreys NE; Kostarelos K
    Biomaterials; 2014 Sep; 35(29):8312-20. PubMed ID: 25002261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells.
    Luo M; Ling T; Xie W; Sun H; Zhou Y; Zhu Q; Shen M; Zong L; Lyu G; Zhao Y; Ye T; Gu J; Tao W; Lu Z; Grummt I
    Stem Cells; 2013 Jul; 31(7):1278-86. PubMed ID: 23533168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
    Sadahiro T; Yamanaka S; Ieda M
    Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
    Hussein SM; Nagy AA
    Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and genetic modification of induced pluripotent stem cells.
    Schambach A; Cantz T; Baum C; Cathomen T
    Expert Opin Biol Ther; 2010 Jul; 10(7):1089-103. PubMed ID: 20528610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does transcription factor induced pluripotency accurately mimic embryo derived pluripotency?
    Lowry WE
    Curr Opin Genet Dev; 2012 Oct; 22(5):429-34. PubMed ID: 23079387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
    Das AK; Pal R
    J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy.
    Yamashita T; Abe K
    Cell Transplant; 2014; 23(4-5):435-9. PubMed ID: 24621988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iPSCs from cancer cells: challenges and opportunities.
    Ramos-Mejia V; Fraga MF; Menendez P
    Trends Mol Med; 2012 May; 18(5):245-7. PubMed ID: 22521522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.